Charles R. Eyler, SEE REMARKS at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 713 shares at $24.80 ($18K) on 2019-01-22, disclosed to the SEC on 2019-01-24.
Scheduled sale ($18k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2018-12-04 | $28K | — | Filing → |
| PBYI | SELL | 2018-07-24 | $32K | — | Filing → |
| PBYI | SELL | 2018-06-04 | $64K | — | Filing → |